Surgepays is trading at $0.12, down 5.38% in pre-market; no new company-specific announcement explaining the October 13 decline has been identified. - The October 9 424B5 filing and Nasdaq bid-price compliance coverage are recent, but available sources do not establish either as the direct cause. - Market context is mixed, with no broad-index decline exceeding 0.5% clearly explaining the move. - Surgepays closed down 8.32% at $0.13 on October 12, extending recent weakness.